To this end, we found that compared with WT-BRAF, ubiquitination-deficient 5KR-BRAF failed to promote MEK/ERK activation in BRAF-depleted melanoma cells (Fig. 7a; Supplementary Fig. 10a–b). Here, MAP2K7 is linked to melanoma.